Immunotherapy approvals shine light on need for molecular testing in endometrial cancer
February 1st 2022SGO
Sarah Lee, MD, MBA, discusses the use of checkpoint inhibitors in endometrial cancer, research regarding the association between MSI-H, dMMR, and TMB-H disease, and the importance of broad molecular testing to ensure all eligible patients are appropriately matched to immunotherapeutic options.
Secondary cytoreductive surgery in recurrent ovarian cancer
SGO
Amer Karam, MD, discusses the role of secondary cytoreductive surgery in ovarian cancer and the need for careful patient selection, plus the results from 3 clinical trials and the key differences between these efforts.
S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person
December 3rd 2021The Menopause Society
In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.
The superior method for pelvic organ prolapse repair: Mesh or native tissue repair?
November 17th 2021AAGL
At AAGL’s 50th Global Congress on MIGS, Peter L. Rosenblatt, MD, and Cheryl B. Iglesia, MD, FACOG, debated the use of native tissue repair and transvaginal mesh in pelvic reconstructive surgery.
Radiofrequency ablation for uterine fibroids
November 16th 2021AAGL
In a panel discussion at AAGL’s 50th Global Congress on MIGS, in Austin, Texas, Kimberly Kho, MD, MPH, along with Jessica Shepherd, MD, MBA, FACOG, and Craig Sobolewski, MD, discussed utilizing radiofrequency ablation for treatment of uterine fibroids.
The need for office hysteroscopies in your practice
November 16th 2021AAGL
“My hysteroscope is my stethoscope. I use it in every opportunity when the story doesn’t match,” Linda D. Bradley, MD, said during her presentation at AAGL’s 50th Global Congress on MIGS, “Office Hysteroscopy: Seeing is Believing. A Manifesto for Change.”
Building a framework for a multidisciplinary approach to chronic pelvic pain therapy
November 15th 2021AAGL
“If you want to provide comprehensive care, it is truly impossible as 1 person,” began Jean Uy-Kroh, MD, FACOG, director, Chronic Pelvic Pain Program at the Cleveland Clinic in Cleveland, Ohio, at AAGL’s 50th Global Congress on MIGS in Austin, Texas.
Inside AAGL 2021: The future of MIGS: globalization and innovation
November 14th 2021AAGL
Hear from Mauricio S. Abrão, MD, PhD, 2021 scientific program chair and upcoming president of AAGL, and Executive Director Linda Michels, discuss key topics and critical updates at AAGL 2021 you don’t want to miss.
AAGL 2021 has officially begun: What to expect from the 50th Global Congress on MIGS
November 14th 2021AAGL
The American Association of Gynecologic Laparoscopists (AAGL) 50th Global Congress on minimally invasive gynecologic surgery (MIGS) begins today and continues through Wednesday, November 17 in Austin, Texas. Follow along for the latest coverage.
From NAMS 2021: The truth about aspirin and statin prescription for CVD prevention
November 10th 2021The Menopause Society
Margo B. Minissian, PhD, shares key updates from the newest recommendations for primary prevention of cardiovascular disease in women from the ACC and AHA. Minissian is executive director, Geri & Richard Brawerman Nursing Institute at Cedars-Sinai Medical Center and the Simms/ Mann Endowed Chair of Nursing Education, Innovation and Research at Cedars-Sinai Medical Center.